Your browser doesn't support javascript.
loading
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Weisberg, Ellen; Chowdhury, Basudev; Meng, Chengcheng; Case, Abigail E; Ni, Wei; Garg, Swati; Sattler, Martin; Azab, Abdel Kareem; Sun, Jennifer; Muz, Barbara; Sanchez, Dana; Toure, Anthia; Stone, Richard M; Galinsky, Ilene; Winer, Eric; Gleim, Scott; Gkountela, Sofia; Kedves, Alexia; Harrington, Edmund; Abrams, Tinya; Zoller, Thomas; Vaupel, Andrea; Manley, Paul; Faller, Michael; Chung, BoYee; Chen, Xin; Busenhart, Philipp; Stephan, Christine; Calkins, Keith; Bonenfant, Debora; Thoma, Claudio R; Forrester, William; Griffin, James D.
Afiliación
  • Weisberg E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ellen_weisberg@dfci.harvard.edu.
  • Chowdhury B; Department of Medicine, Harvard Medical School, Boston, MA, USA. ellen_weisberg@dfci.harvard.edu.
  • Meng C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Case AE; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Ni W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Garg S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sattler M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Azab AK; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Muz B; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Sanchez D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Toure A; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Stone RM; Washington University in Saint Louis School of Medicine, St. Louis, MO, USA.
  • Galinsky I; Washington University in Saint Louis School of Medicine, St. Louis, MO, USA.
  • Winer E; Washington University in Saint Louis School of Medicine, St. Louis, MO, USA.
  • Gleim S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gkountela S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kedves A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Harrington E; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Abrams T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zoller T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Vaupel A; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Manley P; Novartis Pharma AG, Basel, Switzerland.
  • Faller M; Novartis Pharma AG, Basel, Switzerland.
  • Chung B; Novartis Pharma AG, Basel, Switzerland.
  • Chen X; Alphina Therapeutics, Westport, CT, USA.
  • Busenhart P; Novartis Pharma AG, Basel, Switzerland.
  • Stephan C; Novartis Pharma AG, Basel, Switzerland.
  • Calkins K; Novartis Pharma AG, Basel, Switzerland.
  • Bonenfant D; Novartis Pharma AG, Basel, Switzerland.
  • Thoma CR; Novartis Pharma AG, Basel, Switzerland.
  • Forrester W; Novartis Pharma AG, Basel, Switzerland.
  • Griffin JD; Novartis Pharma AG, Basel, Switzerland.
Blood Cancer J ; 12(7): 110, 2022 07 19.
Article en En | MEDLINE | ID: mdl-35853853
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Leucemia Mieloide Aguda / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Leucemia Mieloide Aguda / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos